9 Meters Biopharma (NMTR) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free NMTR Stock Alerts Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media 9 Meters Biopharma Short Interest DataCurrent Short Volume580,600 sharesPrevious Short Volume586,600 sharesChange Vs. Previous Month-1.02%Dollar Volume Sold Short$391,905.00Short Interest Ratio / Days to Cover1.4Last Record DateJuly 15, 2023Outstanding Shares14,336,000 sharesFloat Size14,220,000 sharesShort Percent of Float4.08%Today's Trading Volume253 sharesAverage Trading Volume315,915 sharesToday's Volume Vs. Average0% Short Selling 9 Meters Biopharma ? Sign up to receive the latest short interest report for 9 Meters Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNMTR Short Interest Over TimeNMTR Days to Cover Over TimeNMTR Percentage of Float Shorted Over Time Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> 9 Meters Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2023580,600 shares $391,905.00 -1.0%4.1%1.4 $0.68 6/30/2023586,600 shares $394,195.20 +1.3%4.1%7.8 $0.67 6/15/2023579,000 shares $408,252.90 -1.8%4.1%7.5 $0.71 5/31/2023589,400 shares $412,580.00 +12.7%4.2%6.9 $0.70 5/15/2023523,200 shares $377,750.40 +8.2%3.7%6.6 $0.72 4/30/2023483,400 shares $420,558.00 +1.6%3.4%6.4 $0.87 Get the Latest News and Ratings for NMTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 9 Meters Biopharma and its competitors with MarketBeat's FREE daily newsletter. 4/15/2023475,800 shares $639,951.00 -0.5%3.4%7.9 $1.35 3/31/2023478,100 shares $664,559.00 -2.1%3.4%7 $1.39 3/15/2023488,500 shares $683,900.00 +22.0%3.5%4.5 $1.40 2/28/2023400,300 shares $680,510.00 -7.3%3.1%3.6 $1.70 2/15/2023431,600 shares $953,836.00 -15.7%3.4%3.8 $2.21 1/31/2023512,200 shares $1.03 million +17.3%7.1%4.4 $2.02 1/15/2023436,700 shares $1.02 million +14.8%3.4%3.6 $2.33 12/30/2022380,400 shares $479,304.00 -3.9%3.0%2.9 $1.26 12/15/2022395,800 shares $494,750.00 +41.5%3.1%3.4 $1.25 11/30/2022279,800 shares $478,458.00 +41.8%2.2%2.6 $1.71 11/15/2022197,300 shares $444,911.50 +22.4%1.5%2 $2.26 10/31/2022161,200 shares $414,284.00 +30.5%1.3%1.6 $2.57 10/15/2022123,500 shares $512,278.00 -97.0%1.0%1.1 $4.15 9/30/20224,130,000 shares $887,950.00 +65.9%N/A1.9 $0.22 9/15/20222,490,000 shares $574,194.00 +16.4%N/A0.8 $0.23 8/31/20222,140,000 shares $567,314.00 +13.8%N/A0.5 $0.27 8/15/20221,880,000 shares $545,200.00 -42.0%0.8%0.4 $0.29 7/31/20223,240,000 shares $713,124.00 -37.0%1.3%0.8 $0.22 7/15/20225,140,000 shares $1.25 million -36.2%2.1%1.3 $0.24 6/30/20228,060,000 shares $2.10 million -51.0%3.2%2.1 $0.26 6/15/202216,460,000 shares $9.51 million +7.2%6.9%6.2 $0.58 5/31/202215,350,000 shares $6.94 million +7.4%6.5%11.5 $0.45 5/15/202214,290,000 shares $5.38 million +3.1%6.0%10.6 $0.38 4/30/202213,860,000 shares $5.79 million +10.6%5.9%10.5 $0.42 4/15/202212,530,000 shares $6.79 million +12.7%5.3%9.1 $0.54 3/31/202211,120,000 shares $6.66 million +11.8%4.7%8.3 $0.60 3/15/20229,950,000 shares $5.19 million +6.4%4.3%6.9 $0.52 2/28/20229,350,000 shares $5.11 million +5.2%4.0%6 $0.55 2/15/20228,890,000 shares $6.18 million +6.2%3.8%5.7 $0.70 1/31/20228,370,000 shares $6.39 million +2.7%3.5%5.3 $0.76 1/15/20228,150,000 shares $6.96 million +11.6%3.5%5 $0.85 12/31/20217,300,000 shares $7.15 million +12.0%3.1%4.4 $0.98 12/15/20216,520,000 shares $5.67 million +0.2%2.8%3.7 $0.87 11/30/20216,510,000 shares $6.77 million -7.0%2.8%3.6 $1.04“The Stock Market’s Bull Run is Far from Over” -Barrons (Ad)Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… NMTR Short Interest - Frequently Asked Questions What is 9 Meters Biopharma's current short interest? Short interest is the volume of 9 Meters Biopharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 580,600 shares of NMTR short. 4.08% of 9 Meters Biopharma's shares are currently sold short. Learn More on 9 Meters Biopharma's current short interest. What is a good short interest ratio for 9 Meters Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NMTR shares currently have a short interest ratio of 1.0. Learn More on 9 Meters Biopharma's short interest ratio. What is a good short interest percentage for 9 Meters Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.08% of 9 Meters Biopharma's floating shares are currently sold short. Is 9 Meters Biopharma's short interest increasing or decreasing? 9 Meters Biopharma saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 580,600 shares, a decline of 1.0% from the previous total of 586,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is 9 Meters Biopharma's float size? 9 Meters Biopharma currently has issued a total of 14,336,000 shares. Some of 9 Meters Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 9 Meters Biopharma currently has a public float of 14,220,000 shares. How does 9 Meters Biopharma's short interest compare to its competitors? 4.08% of 9 Meters Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to 9 Meters Biopharma: Aptevo Therapeutics Inc. (5.46%), Biodexa Pharmaceuticals Plc (7.95%), Cingulate Inc. (0.29%), Bluejay Diagnostics, Inc. (0.14%), InVivo Therapeutics Holdings Corp. (0.57%), Comera Life Sciences Holdings, Inc. (2.38%), Agile Therapeutics, Inc. (12.68%), SciSparc Ltd. (5.67%), TC Biopharm (Holdings) Plc (93.93%), Evelo Biosciences, Inc. (2.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short 9 Meters Biopharma stock? Short selling NMTR is an investing strategy that aims to generate trading profit from 9 Meters Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 9 Meters Biopharma? A short squeeze for 9 Meters Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NMTR, which in turn drives the price of the stock up even further. How often is 9 Meters Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMTR, twice per month. The most recent reporting period available is July, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Aptevo Therapeutics Short Interest Biodexa Pharmaceuticals Short Interest Cingulate Short Interest Bluejay Diagnostics Short Interest InVivo Therapeutics Short Interest Comera Life Sciences Short Interest Agile Therapeutics Short Interest SciSparc Short Interest TC Biopharm Short Interest Evelo Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NMTR) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics